You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)

    SBC: NANOVALENT PHARMACEUTICALS INC            Topic: 102

    Project Summary The goal of this Fast Track STTR project is to determine proof-of-principle and efficacy of a novel blood brain barrier (BBB) penetrating therapeutic nanoparticle for the potential treatment of otherwise intractable brain tumors like glioblastoma multiforme (GBM). This project seeks to demonstrate that novel, targetable nanoparticles can delivery therapeutic substances to human bra ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. Booth™ by Opio™: Developing technology to expand the reach of opioid treatment programs into rural and underserved areas.

    SBC: Opio Connect, Inc.            Topic: NIDA

    The goal of this project is to develop a treatment booth with technology that allows opioid treatment programs to remotely dispense, either methadone or buprenorphine, under medical observation through telemedicine to a patient in a treatment booth. We believe that robotic automation is the ideal application to perform the same mechanical functions of the nurse at the dosing window. Specifically, ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  3. Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options

    SBC: Golden Helix, Inc.            Topic: 172

    Abstract Pharmacogenomics, the study of how an individual's genetic makeup affects their response to drugs, has undergone rapid advancements. This has occurred alongside a decrease in the cost of genotyping technology, making implementation of pharmacogenomics into clinical practice increasingly feasible. Personalized medicine leveraging pharmacogenomics is gaining momentum to optimize drug choice ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Selective CYP26 inhibitors for the oral treatment of recalcitrant nodular acne.

    SBC: DERMAXON LLC            Topic: NIAMS

    Project Summary / Abstract DermaXon's project goal is to develop efficacious, substrate-based, selective inhibitors of CYP26s, the enzymes responsible for the metabolism of all-trans retinoic acid (atRA) in the epidermis, as an oral treatment for severe recalcitrant acne. This approach will provide an improved acne therapeutic without the adverse effects associated with currently marketed retinoid ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  5. Biomineralization using in situ materials to enhance Rapid Airfield Damage Recovery (RADR) and Development of Expeditionary Airfields

    SBC: BIOSQUEEZE INC            Topic: AFX236DPCSO1

    Select microbes contain an enzyme that promotes the hydrolysis of urea (ureolysis). This triggers an increase in pH and carbonate concentrations that, in turn, can cause dissolved minerals to precipitate and form solids similar to limestone. Recent resear

    SBIR Phase II 2023 Department of DefenseAir Force
  6. High Purity Entanglement Generation Using Complex Domain Engineering

    SBC: ADVR, INC.            Topic: SF22DT004

    The overall goal of this multiphase STTR program is to develop a pulsed source of high purity entangled photons suitable for use at the Air Force’s Starfire free space optical range to support advances in free space quantum networking hardware and protoco

    STTR Phase I 2023 Department of DefenseAir Force
  7. Waveguide-Based, high heralding efficiency biphoton source

    SBC: ADVR, INC.            Topic: SF22DT005

    The overall goal of this multiphase STTR program is to develop fully packaged waveguide-based biphoton sources with high brightness and ultra-high, well characterized heralding efficiency. The specific goal of this phase I STTR is to establish the feasibi

    STTR Phase I 2023 Department of DefenseAir Force
  8. LPD & LPI Ultra-low SWaP-C Mesh Networking For Secure Communications In Near-peer Contested Environments

    SBC: BEARTOOTH RADIO, INC.            Topic: AFX235CSO1

      Mission success in contingency operations depends on communication and Beartooth Radio provides a solution when traditional comms are degraded; saving lives by reducing much-needed time battle-tracking friendlies and engaging the enemy when and where it

    SBIR Phase I 2023 Department of DefenseAir Force
  9. Man Portable HF Antenna for Contested, Degraded ACE Operations

    SBC: HI-Q-MILITARY ANTENNAS-AES LLC            Topic: AFX235CSO1

    The Hi-Q Military Antenna product is compact, high power, mobile high frequency (HF) radio antennas for the US military, allied nations and commercial customers world-wide. This product enables customers to communicate rapidly, using HF radios, over long

    SBIR Phase I 2023 Department of DefenseAir Force
  10. Expeditionary HF Antennas for Distributed Combat Power Production under DAF ACE Construct

    SBC: HI-Q-MILITARY ANTENNAS-AES LLC            Topic: AFX23DTCSO1

    The Hi-Q Military Antenna product is compact, high power, mobile high frequency (HF) radio antennas for the US military, allied nations and commercial customers world-wide. This product enables customers to communicate rapidly, using HF radios, over-the-h

    STTR Phase I 2023 Department of DefenseAir Force
US Flag An Official Website of the United States Government